[HTML][HTML] Hyperimmune anti-COVID-19 IVIG (C-IVIG) treatment in severe and critical COVID-19 patients: A phase I/II randomized control trial

S Ali, SM Uddin, E Shalim, MA Sayeed, F Anjum… - …, 2021 - thelancet.com
Abstract Background Hyperimmune anti-COVID-19 Intravenous Immunoglobulin (C-IVIG) is
an unexplored therapy amidst the rapidly evolving spectrum of medical therapies for COVID …

[PDF][PDF] Hyperimmune anti-COVID-19 IVIG (C-IVIG) treatment in severe and critical COVID-19 patients: A phase I/II randomized control trial

SM Uddina, E Shalima, MA Sayeedb, F Anjumc… - 2021 - academia.edu
ABSTRACT Background: Hyperimmune anti-COVID-19 Intravenous Immunoglobulin (C-
IVIG) is an unexplored therapy amidst the rapidly evolving spectrum of medical therapies for …

[HTML][HTML] Hyperimmune anti-COVID-19 IVIG (C-IVIG) treatment in severe and critical COVID-19 patients: A phase I/II randomized control trial

S Ali, SM Uddin, E Shalim, MA Sayeed, F Anjum… - EClinicalMedicine, 2021 - Elsevier
Abstract Background Hyperimmune anti-COVID-19 Intravenous Immunoglobulin (C-IVIG) is
an unexplored therapy amidst the rapidly evolving spectrum of medical therapies for COVID …

[HTML][HTML] Hyperimmune anti-COVID-19 IVIG (C-IVIG) treatment in severe and critical COVID-19 patients: A phase I/II randomized control trial

S Ali, SM Uddin, E Shalim, MA Sayeed, F Anjum… - …, 2021 - ncbi.nlm.nih.gov
Background Hyperimmune anti-COVID-19 Intravenous Immunoglobulin (C-IVIG) is an
unexplored therapy amidst the rapidly evolving spectrum of medical therapies for COVID-19 …

Hyperimmune anti-COVID-19 IVIG (C-IVIG) treatment in severe and critical COVID-19 patients: A phase I/II randomized control trial

S Ali, SM Uddin, E Shalim, MA Sayeed… - …, 2021 - pubmed.ncbi.nlm.nih.gov
Background Hyperimmune anti-COVID-19 Intravenous Immunoglobulin (C-IVIG) is an
unexplored therapy amidst the rapidly evolving spectrum of medical therapies for COVID-19 …

Hyperimmune anti-COVID-19 IVIG (C-IVIG) treatment in severe and critical COVID-19 patients: A phase I/II randomized control trial.

S Ali, SM Uddin, E Shalim, MA Sayeed, F Anjum… - …, 2021 - europepmc.org
Background Hyperimmune anti-COVID-19 Intravenous Immunoglobulin (C-IVIG) is an
unexplored therapy amidst the rapidly evolving spectrum of medical therapies for COVID-19 …

[PDF][PDF] Hyperimmune anti-COVID-19 IVIG (C-IVIG) treatment in severe and critical COVID-19 patients: A phase I/II randomized control trial

SM Uddina, E Shalima, MA Sayeedb, F Anjumc… - 2021 - academia.edu
ABSTRACT Background: Hyperimmune anti-COVID-19 Intravenous Immunoglobulin (C-
IVIG) is an unexplored therapy amidst the rapidly evolving spectrum of medical therapies for …